Findings from several studies have consistently found that genetic polymorphisms in IGF1 and/or IGFBP3 are associated with the risk or prognosis of various cancers, including colorectal cancer14, lung cancer15, prostate cancer16, and breast cancer17. This evidence concerns the gene IGF1 and cancer.